[HTML][HTML] Pituitary neuroendocrine tumors: a model for neuroendocrine tumor classification

SL Asa, O Mete, MD Cusimano, IE McCutcheon… - Modern Pathology, 2021 - Elsevier
The classification of adenohypophysial neoplasms as “pituitary neuroendocrine
tumors”(PitNETs) was proposed in 2017 to reflect their characteristics as epithelial …

The use of augmented reality in transsphenoidal surgery: A systematic review

SG Thavarajasingam, R Vardanyan… - British journal of …, 2022 - Taylor & Francis
Background Augmented reality (AR) has become a promising tool in neurosurgery. It can
minimise the anatomical challenges faced by conventional endoscopic or microscopic …

The clinicopathological features and prognosis of silent corticotroph tumors: an updated systematic review and meta-analysis

HG Vuong, IF Dunn - Endocrine, 2023 - Springer
Introduction Data on silent corticotroph tumor (SCT) are still heterogeneous and
controversial. In this study, we aimed to compare the demographic, clinicopathological …

Non-functioning pituitary macroadenoma following surgery: long-term outcomes and development of an optimal follow-up strategy

Z Hussein, J Grieve, N Dorward, K Miszkiel… - Frontiers in …, 2023 - frontiersin.org
Objectives Recurrence and regrowth of non-functioning pituitary macroadenomas (NFPMs)
after surgery are common but remain unpredictable. Therefore, the optimal timing and …

Clinical, pathologic, and imaging characteristics of pituitary null cell adenomas as defined according to the 2017 World Health Organization criteria: a case series from …

JP Almeida, CC Stephens, JM Eschbacher… - Pituitary, 2019 - Springer
Abstract Purpose The 2017 World Health Organization classification of pituitary tumors
redefined pituitary null cell adenomas (NCAs) by restricting this diagnostic category to …

Analysis of related factors of tumor recurrence or progression after transnasal sphenoidal surgical treatment of large and giant pituitary adenomas and establish a …

Y Chen, F Cai, J Cao, F Gao, Y Lv, Y Tang… - Frontiers in …, 2021 - frontiersin.org
Background Pituitary adenoma (PA) is a benign neuroendocrine tumor caused by
adenohypophysial cells, and accounts for 10%-20% of all primary intracranial tumors. The …

The Role of Augmented Reality Neuronavigation in Transsphenoidal Surgery: A Systematic Review

BM Campisi, R Costanzo, V Gulino, C Avallone, M Noto… - Brain Sciences, 2023 - mdpi.com
In the field of minimally invasive neurosurgery, microscopic transsphenoidal surgery (MTS)
and endoscopic transsphenoidal surgery (ETS) have been widely accepted as a safe …

Post-operative surveillance for somatotroph, lactotroph and non-functional pituitary adenomas after curative resection: a systematic review

L Caulley, J Whelan, M Khoury, D Mavedatnia… - Pituitary, 2023 - Springer
Context Pituitary tumors are the third most common brain tumor and yet there is no
standardization of the surveillance schedule and assessment modalities after …

Clinicopathological analysis of 250 cases of pituitary adenoma under the new WHO classification

J Liu, Y He, X Zhang, X Yan… - Oncology letters, 2020 - spandidos-publications.com
Pituitary adenomas (PAs) are a common subtype of intracranial tumors. The aim of the
present study was to analyse the clinical and pathological features of different types of …

Guidelines in the management of CNS tumors

N Redjal, AS Venteicher, D Dang, A Sloan… - Journal of neuro …, 2021 - Springer
Introduction Evidence-based, clinical practice guidelines in the management of central
nervous system tumors (CNS) continue to be developed and updated through the work of …